InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,266.96
(
0.28%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: BTH post# 133359

Monday, 12/19/2011 6:57:06 PM

Monday, December 19, 2011 6:57:06 PM

Post# of 252302
A PhRMA survey conducted in 2005 found that, on average, it takes 15 years to bring a new oncology drug to market - 6.5 years to move from discovery to clinical trials and an additional 8.5 years to conduct the necessary trials and receive approval. But of course, this was before the FDA announced their "Program to Streamline Cancer Drug Development" in 2009.

(as an aside, Ariad is on track to bring ponatinib to market in about half that time but then again it took'em 20 years to get ridaforolimus to NDA, so, on average....lol.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up